Skip to main content

MD, PhD Morten Frost receives prestigious grant from the Novo Nordisk Foundation

10 million DKK to support studies on the role of the hormone GLP-1 and the potential of GLP-1 like drugs to be used as a treatment for skeletal fragility in patients with osteoporosis or diabetes

MD, PhD Morten Frost has received the prestigious Excellence Emerging Investigator Grant – Endocrinology & Metabolism 2019 from the Novo Nordisk Foundation for the project GLucagon-like peptide One & BonE (GLOBE): Studies on the role of GLP-1 as a nutrient sensing mechanism regulating bone metabolism 

Further information on SDCO's webpage

Editing was completed: 12.04.2019